Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutao Cui

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Nature Communications|July 13, 2016
Germline MC1R status influences somatic mutation burden in melanomaCarla Daniela Robles-Espinoza, Nicola D Roberts, Shuyang Chen, et al.
Plos Biology|December 2, 2024
Melanocortin 1 receptor mediates melanin production by interacting with the BBSome in primary ciliaXiaoyu Tian, Hanyu Wang, Song Liu, et al.
Cell|March 14, 2007
Central role of p53 in the suntan response and pathologic hyperpigmentationRutao Cui, Hans R Widlund, Erez Feige, et al.
Cell Death & Disease|May 2, 2025
KLF7-regulated ITGA2 as a therapeutic target for inhibiting oral cancer stem cellsXin Qi, Jiang Zhou, Pan Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 16, 2022
Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasisJingjing Zhang, Yun Li, Hua Liu, et al.
Nature Communications|February 22, 2019
Targeting MC1R depalmitoylation to prevent melanomagenesis in redheadsShuyang Chen, Changpeng Han, Xiao Miao, et al.
Gastroenterology|September 17, 2013
MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagyChangming Lu, Jianfeng Chen, Hua-Guo Xu, et al.
Nature|September 5, 2017
Palmitoylation-dependent activation of MC1R prevents melanomagenesisShuyang Chen, Bo Zhu, Chengqian Yin, et al.
Science Advances|July 11, 2025
UFMylation maintains tumor suppressor pVHL stability by activating the deubiquitinase BAP1Xiao Yang, Yalei Wen, Shengying Qin, et al.
Oncogene|May 23, 2018
Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapyBo Zhu, Liming Tang, Shuyang Chen, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Nature Communications|July 13, 2016
Germline MC1R status influences somatic mutation burden in melanomaCarla Daniela Robles-Espinoza, Nicola D Roberts, Shuyang Chen, et al.
Plos Biology|December 2, 2024
Melanocortin 1 receptor mediates melanin production by interacting with the BBSome in primary ciliaXiaoyu Tian, Hanyu Wang, Song Liu, et al.
Cell|March 14, 2007
Central role of p53 in the suntan response and pathologic hyperpigmentationRutao Cui, Hans R Widlund, Erez Feige, et al.
Cell Death & Disease|May 2, 2025
KLF7-regulated ITGA2 as a therapeutic target for inhibiting oral cancer stem cellsXin Qi, Jiang Zhou, Pan Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 16, 2022
Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasisJingjing Zhang, Yun Li, Hua Liu, et al.
Nature Communications|February 22, 2019
Targeting MC1R depalmitoylation to prevent melanomagenesis in redheadsShuyang Chen, Changpeng Han, Xiao Miao, et al.
Gastroenterology|September 17, 2013
MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagyChangming Lu, Jianfeng Chen, Hua-Guo Xu, et al.
Nature|September 5, 2017
Palmitoylation-dependent activation of MC1R prevents melanomagenesisShuyang Chen, Bo Zhu, Chengqian Yin, et al.
Science Advances|July 11, 2025
UFMylation maintains tumor suppressor pVHL stability by activating the deubiquitinase BAP1Xiao Yang, Yalei Wen, Shengying Qin, et al.
Oncogene|May 23, 2018
Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapyBo Zhu, Liming Tang, Shuyang Chen, et al.
Pageof 6